The Discounted Cash Flow (DCF) valuation of Neurocrine Biosciences Inc (NBIX) is 151.06 USD. With the latest stock price at 121.02 USD, the upside of Neurocrine Biosciences Inc based on DCF is 24.8%.
Based on the latest price of 121.02 USD and our DCF valuation, Neurocrine Biosciences Inc (NBIX) is a buy. buying NBIX stocks now will result in a potential gain of 24.8%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.0% | 7.2% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 108.14 - 275.66 | 151.06 |
| Upside | -10.6% - 127.8% | 24.8% |